VR Logo

Advanced Enzyme Technologies Ltd.


FMCG | Food Processing

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1989

Chairman: Vasant Rathi

Managing Director: --

Group: --

Listing: NSE: ADVENZYMES, BSE: 540025

Headquarters: Thane, Maharashtra

Website: www.advancedenzymes.com

Key Facts

Market cap: R 1,970.53 Cr

Revenue (TTM): R 433.94 Cr

Earnings (TTM): R 124.62 Cr

Cash: R 134.40 Cr

Total Debt: R 35.03 Cr

Promoters' ownership: 57.86%

Liquidity: High

52 Week range: R 142.40 - 224.90

Face value: R2.00

Shares outstanding: 11,16,76,475

Stock Performance

Time Period Advanced Enzyme Technologies S&P BSE FMCG S&P BSE Small Cap
YTD10.304.698.37
1 month10.344.3710.92
3 months13.81-0.6212.43
1 Year14.172.034.36
3 Years-20.9111.534.71
5 Years--8.015.48
10 Years--15.715.53
As on 24-Jan-2020
Year Advanced Enzyme Technologies S&P BSE Small Cap S&P BSE FMCG
2019-5.86-6.85-3.58
2018-36.14-23.4110.54
2017-30.0459.6431.54